Protocol Service
Sexual Health
PT-141 (Bremelanotide) in Scarsdale, NY
Protocol Health prescribes PT-141 (bremelanotide) for low sexual desire at our Scarsdale, NY clinic and by telehealth, after a provider review. It acts on the brain rather than on blood flow.
Consultation $249, or $349 with blood work.
The FDA-approved product, Vyleesi, is labeled only for premenopausal women with acquired, generalized low sexual desire; use in men or postmenopausal women is off-label, and compounded bremelanotide is not FDA-approved.
Medically reviewed by Richard Dentico, MD, Medical Director
★ 5.0 on Google · 107 reviews (as of October 2026) · Physician-led, family-owned
Our Scarsdale clinic serves Westchester County. Telehealth in NY, NJ, CT, FL and CA.
Book Now
PT-141 (Bremelanotide) at Protocol Health
Before you book
How PT-141 differs from ED pills
PT-141 is a peptide that acts on melanocortin receptors in the brain to influence arousal centrally. Sildenafil and tadalafil work on blood flow. That makes PT-141 a desire treatment rather than an erection treatment, and it is offered as a vial or nasal spray.
Who asks about PT-141?
Adults with low desire after other causes are reviewed.
- Low sexual desire that bothers you
- Hormone and medication causes reviewed
- Understand it is off-label for most uses
What to know
Regulatory status varies by product and patient.
Vyleesi. Approved for premenopausal women with acquired, generalized low desire.
Off-label. Use in men or postmenopausal women is off-label.
Compounded. Compounded bremelanotide is not FDA-approved.
How PT-141 is used
Desire, not blood flow. Acts centrally on arousal pathways.
Vial or nasal spray. Both forms are offered.
Review first. Blood pressure and history checked.
For men and women. Off-label outside Vyleesi's labeled use.
Starting PT-141
In the Scarsdale clinic or by telehealth where appropriate.
- Consultation. Desire, hormones, medications.
- Review. Blood pressure and history.
- Prescription. Vial or nasal spray.
- Follow-up. Whether it helps.
Common questions
PT-141 (Bremelanotide): frequently asked questions
Is PT-141 FDA-approved?
As Vyleesi, for premenopausal women with acquired, generalized low desire. Other uses are off-label, and compounded bremelanotide is not FDA-approved.
Does PT-141 treat ED?
It targets desire through the brain rather than blood flow.
Is it a nasal spray?
Protocol Health offers a vial and a nasal spray.
Contact Us
Book Your Appointment Today
Fill out the form below to schedule your visit with our expert team.